Elanco, the animal health business of Eli Lilly, has filed for an IPO, setting in motion the process of splitting from its parent company of more than 60 years.
Greenfield, IN-based Elanco set a preliminary $100 million target in the IPO filing, a figure used to calculate the registration fee. IPO research firm Renaissance Capital estimates that Elanco’s IPO-if it happens-could raise as much as $2.5 billion. Elanco has yet to determine how many shares it will sell and at what price. It has applied for a New York Stock Exchange listing under the stock symbol “ELAN.”
The Elanco IPO plans… Read more »
UNDERWRITERS AND PARTNERS